Skip to main content
. 2018 Jun 29;8(3):228–236. doi: 10.1159/000489097

Table 2.

Baseline characteristics of the diabetic patients in the study population

Normal renal function (n = 627) Mild CKD (n = 887) Moderate CKD (n = 111) p
Age, years 56.3±10.3 60.6±10.2 69.1±8.6 <0.001
Male 451 (71.9) 637 (71.8) 56 (50.5) <0.001
Body mass index 24.7±3.6 25.0±3.3 25.0±2.9 0.145
SBP, mm Hg 124.8±14.6 125.4±13.9 130.0±16.3 0.003
DBP, mm Hg 76.1±10.4 75.4±10.0 75.1±9.1 0.355
Hypertension 239 (40.1) 404 (47.8) 87 (79.1) <0.001
Smoking 167 (42.4) 195 (37.1) 19 (22.4) 0.002
Dyslipidemia 288 (45.9) 460 (51.9) 72 (64.9) 0.001

Hemoglobin, mg/dL 14.4±1.5 14.3±1.7 13.0±1.7 <0.001
eGFR 103.6±13.0 78.0±7.7 52.5±7.1 <0.001
Total cholesterol, mL/dL 183.1±39.4 185.3±40.2 169.5±43.2 0.001
Triglyceride, mL/dL 139.1±107.6 134.3±88.3 139.1±66.8 0.606
HDL cholesterol, mL/dL 49.1±12.2 48.2±11.5 46.2±11.4 0.042
LDL cholesterol, mL/dL 107.7±34.1 112.6±35.7 100.7±40.4 0.003
HbA1C, % 9.1±3.7 9.5±4.0 8.7±3.5 0.037
hs-CRP, mg/L 3.4±1.2 3.6±1.4 6.5±3.4 0.287

Data are given as the mean ± SD or n (%). CKD, chronic kidney disease; SBP, systolic blood pressure; DBP, diastolic blood pressure; eGFR, estimated glomerular filtration rate; HDL, high-density lipoprotein; LDL, low-density lipoprotein; HbA1C, glycosylated hemoglobin; hs-CRP, high-sensitivity C-reactive protein.